Glover Stephen C. has filed 8 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 54876 shares of PDS Biotechnology Corp ($PDSB) on January 12, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | PDS Biotechnology Corp | $PDSB | Glover Stephen C. | Not found | A | Employee Stock Option (Right to Buy) | 54876 | $0.00 | 54,876.0000 | 48,980,307 | 9999.99% | 0.11% |
| July 11, 2025 | ZyVersa Therapeutics, Inc. | $ZVSA | Glover Stephen C. | Chief Executive Officer | A | Stock Options | 136900 | $0.00 | 136,900.0000 | 2,568,191 | 9999.99% | 5.33% |
| June 11, 2025 | PDS Biotechnology Corp | $PDSB | Glover Stephen C. | Not found | A | Employee Stock Option (Right to Buy) | 22700 | $0.00 | 22,700.0000 | 45,395,851 | 9999.99% | 0.05% |
| Feb. 28, 2025 | PDS Biotechnology Corp | $PDSB | Glover Stephen C. | Not found | P | Common Stock | 15061 | $1.66 | 78,851.0000 | 0 | 23.61% | 0.00% |
| Feb. 28, 2025 | PDS Biotechnology Corp | $PDSB | Glover Stephen C. | Not found | P | Common Warrant | 15061 | $0.00 | 15,061.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | ZyVersa Therapeutics, Inc. | $ZVSA | Glover Stephen C. | Chief Executive Officer | A | Stock Options | 1627 | $0.00 | 1,627.0000 | 0 | 9999.99% | 0.00% |
| June 24, 2024 | PDS Biotechnology Corp | $PDSB | Glover Stephen C. | Not found | A | Employee Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| July 14, 2023 | PDS Biotechnology Corp | $PDSB | Glover Stephen C. | Not found | A | Employee Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |